CLINICAL TRIALS AT
SCCA has over 200 clinical trials open for patients and intends to lead the world in translating scientific discovery into the prevention, diagnosis, treatment and cure of cancer.
Recently Opened Trials
An Open-label, Multicenter, Single-arm, Phase 2 Study of PCI-32765 (Ibrutinib) in Subjects With Refractory Follicular Lymphoma
Cellular Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes Following Lymphodepletion With Cyclophosphamide and Fludarabine For Patients With Metastatic Melanoma
A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer